Meta-Analysis: The Clinical Application of Autologous Adult Stem Cells in the Treatment of Stroke

References

• Johnson W, Onuma O, Owolabi M, Sachdev S. Stroke: a global response is needed. Bull World Health Organ. 2016;94(9):634A–635A. doi:10.2471/BLT.16.181636
   PubMed Web of Science ®Google Scholar
• Donnan G, Fisher M, Maclead M, Davis S. Stroke. Lancet. 2008;373(9674):1496. doi:10.1016/S0140-6736(09)60833-3
   Google Scholar
• Umut Canbek YB, Imerci A, Akgün U, Yesil M, Aydin A. Characteristics of injuries caused by paragliding accidents: a cross-sectional study. World J Emerg Med. 2015;6(1):44–47. doi:10.5847/wjem.j.1920
   Google Scholar
• Roth EJ, Heinemann AW, Lovell LL, Harvey RL, McGuire JR, Diaz S. Impairment and disability: their relation during stroke rehabilitation. Arch Phys Med Rehabil. 1998;79(3):329–335. doi:10.1016/S0003-9993(98)90015-6
   PubMed Web of Science ®Google Scholar
• Joy MT, Carmichael ST. Encouraging an excitable brain state: mechanisms of brain repair in stroke. Nat Rev Neurosci. 2021. doi:10.1038/s41583-020-00396-7
   Web of Science ®Google Scholar
• Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014;115:157–188. doi:10.1016/j.pneurobio.2013.11.006
   PubMed Web of Science ®Google Scholar
• Fern R, Matute C. Glutamate receptors and white matter stroke. Neurosci Lett. 2019;694:86–92. doi:10.1016/j.neulet.2018.11.031
   Web of Science ®Google Scholar
• Zhao L, Willing A. Progress in neurobiology enhancing endogenous capacity to repair a stroke-damaged brain: an evolving fi eld for stroke research. Prog Neurobiol. 2018;163–164:5–26. doi:10.1016/j.pneurobio.2018.01.004
   PubMed Web of Science ®Google Scholar
• Hasan TF, Rabinstein AA, Middlebrooks EH, et al. Diagnosis and management of acute ischemic stroke. Mayo Clin Proc Themat Rev Neurosci. 2018;93(4):523–538. doi:10.1016/j.mayocp.2018.02.013
   PubMed Web of Science ®Google Scholar
• Abraham MK, Chang WTW. Subarachnoid hemorrhage. Emerg Med Clin NA. 2016;34(4):901–916. doi:10.1016/j.emc.2016.06.011
   PubMed Web of Science ®Google Scholar
• Wei L, Wei ZZ, Jiang MQ, Mohamad O, Yu SP. Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. Prog Neurobiol. 2017. doi:10.1016/j.pneurobio.2017.03.003
   Web of Science ®Google Scholar
• Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24(2):98–103. doi:10.1097/JCN.0b013e318197a6a5
   PubMed Web of Science ®Google Scholar
• Larijani B, Esfahani EN, Amini P, et al. Stem cell therapy in treatment of different diseases. Acta Med Iran. 2012;50(2):79–96.
   Google Scholar
• Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009;30(3):204–213. doi:10.1210/er.2008-0031
   PubMed Web of Science ®Google Scholar
• Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116(5):639–648. doi:10.1016/S0092-8674(04)00208-9
   PubMed Web of Science ®Google Scholar
• Fernández-Susavila H, Bugallo-Casal A, Castillo J, Campos F. Adult stem cells and induced pluripotent stem cells for stroke treatment. Front Neurol. 2019;10. doi:10.3389/fneur.2019.00908
   Web of Science ®Google Scholar
• Bang OY. Current status of cell therapies in stroke. Int J Stem Cells. 2009;2(1):35–44. doi:10.15283/ijsc.2009.2.1.35
   Google Scholar
• Einstein O, Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol. 2008;65(4):452–456. doi:10.1001/archneur.65.4.452
   PubMedGoogle Scholar
• Dabrowska S, Andrzejewska A, Lukomska B, Janowski M. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation. 2019;16(1):1–17. doi:10.1186/s12974-019-1571-8
   Web of Science ®Google Scholar
• Wagenaar N, Nijboer CHA, Van Bel F. Repair of neonatal brain injury: bringing stem cell-based therapy into clinical practice. Dev Med Child Neurol. 2017;59(10):997–1003. doi:10.1111/dmcn.13528
   PubMed Web of Science ®Google Scholar
• Secunda R, Vennila R, Mohanashankar AM, Rajasundari M, Jeswanth S, Surendran R. Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology. 2015;67(5):793–807. doi:10.1007/s10616-014-9718-z
   PubMed Web of Science ®Google Scholar
• Lin CS, Xin ZC, Dai J, Lue TF. Commonly used mesenchymal stem cell markers and tracking labels: limitations and challenges. Histol Histopathol. 2013;28(9):1109–1116. doi:10.14670/HH-28.1109
   PubMed Web of Science ®Google Scholar
• Maleki M, Ghanbarvand F, Behvarz MR, Ejtemaei M, Ghadirkhomi E. Comparison of mesenchymal stem cell markers in multiple human adult stem cells. Int J Stem Cells. 2014;7(2):118–126. doi:10.15283/ijsc.2014.7.2.118
   PubMedGoogle Scholar
• Bhartiya D. Clinical translation of stem cells for regenerative medicine: a comprehensive analysis. Circ Res. 2019;124(6):840–842. doi:10.1161/CIRCRESAHA.118.313823
   Web of Science ®Google Scholar
• Lv W, Li WY, Xu XY, Jiang H, Bang OY. Bone marrow mesenchymal stem cells transplantation promotes the release of endogenous erythropoietin after ischemic stroke. Neural Regen Res. 2015;10(8):1265–1270. doi:10.4103/1673-5374.162759
   PubMed Web of Science ®Google Scholar
• Muir T. Peripheral blood mononuclear cells: a brief review origin of peripheral blood mononuclear cells; 2020:1–7.
   Google Scholar
• Wang Z, Schuch G, Williams JK, Soker S. Peripheral blood stem cells. Handb Stem Cells. 2013;2:573–586. doi:10.1016/B978-0-12-385942-6.00050-0
   Google Scholar
• Lee JS, Hong JM, Moon GJ, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.. Stem Cells. 2010;28(6):1099–1106. doi:10.1002/stem.430
   PubMed Web of Science ®Google Scholar
• Honmou O, Houkin K, Matsunaga T, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011;134(6):1790–1807. doi:10.1093/brain/awr063
   Web of Science ®Google Scholar
• Banerjee S. T ISSUE -S PECIFIC P ROGENITOR AND S TEM C ELLS intra-arterial immunoselected CD34 + stem cells for acute ischemic stroke; 2014.
   Google Scholar
• Bhasin A, Padma Srivastava MV, Mohanty S, Bhatia R, Kumaran SS, Bose S. Stem cell therapy: a clinical trial of stroke. Clin Neurol Neurosurg. 2013;115(7):1003–1008. doi:10.1016/j.clineuro.2012.10.015
   PubMed Web of Science ®Google Scholar
• Prasad K, Sharma A, Garg A, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke. 2014;45(12):3618–3624. doi:10.1161/STROKEAHA.114.007028
   PubMed Web of Science ®Google Scholar
• Chen DC, Lin S-Z, Fan J-R, et al. Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized Phase II study. Cell Transplantation. 2014;23(12):1599–1612. doi:10.3727/096368914X678562
   Web of Science ®Google Scholar
• Taguchi A, Sakai C, Soma T, et al. Intravenous autologous bone marrow mononuclear cell transplantation for stroke: phase1/2a clinical trial in a homogeneous group of stroke patients. Stem Cells Dev. 2015;24(19):2207–2218. doi:10.1089/scd.2015.0160
   PubMed Web of Science ®Google Scholar
• Bhatia V, Gupta V, Khurana D, Sharma RR, Khandelwal N. Randomized assessment of the safety and efficacy of intra-arterial infusion of autologous stem cells in subacute ischemic stroke. Am J Neuroradiol. 2018;39(5):899–904. doi:10.3174/ajnr.A5586
   Web of Science ®Google Scholar
• Duma C, Kopyov O, Kopyov A, et al. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year Phase 1 study of 113 injections in 31 patients. Mol Biol Rep. 2019;46(5):5257–5272. doi:10.1007/s11033-019-04983-5
   PubMed Web of Science ®Google Scholar
• Savitz SI, Yavagal D, Rappard G, et al. A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-stroke). Circulation. 2019;139(2):192–205. doi:10.1161/CIRCULATIONAHA.117.030659
   PubMed Web of Science ®Google Scholar
• Jaillard A, Hommel M, Moisan A, et al. Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial. Transl Stroke Res. 2020;11(5):910–923. doi:10.1007/s12975-020-00787-z
   PubMed Web of Science ®Google Scholar
• Kwak K-A, Kwon H-B, Lee JW, Park Y-S. Current perspectives regarding stem cell-based therapy for ischemic stroke. Curr Pharm Des. 2018;24(28):3332–3340. doi:10.2174/1381612824666180604111806
   Web of Science ®Google Scholar
• Anastasian ZH. Anaesthetic management of the patient with acute ischaemic stroke. Br J Anaesth. 2014;113:ii9–ii16. doi:10.1093/bja/aeu372
   Web of Science ®Google Scholar